Outlook Therapeutics Inc. buy Warner
Start price
27.11.24
/
0%
€0.85
Target price
27.11.25
-
Performance (%)
112.94%
End price
03.12.24
€1.81
Summary
This prediction ended on 03.12.24 with a price of €1.81. The BUY prediction by Warner for Outlook Therapeutics Inc. saw massive gains of 112.94%. Warner has a follow-up prediction for Outlook Therapeutics Inc. where he still thinks Outlook Therapeutics Inc. is a Buy. This prediction was marked as speculative and is excluded from Warner's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Outlook Therapeutics Inc. | 39.087% | 39.087% |
| iShares Core DAX® | -2.597% | -2.126% |
| iShares Nasdaq 100 | -3.356% | 0.640% |
| iShares Nikkei 225® | -4.112% | 0.711% |
| iShares S&P 500 | -2.520% | 0.874% |
According to Warner what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Little innovation
Comments by Warner for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy Outlook Therapeutics Inc.
In the thread Trading Outlook Therapeutics Inc.
Current prediction by Warner for Outlook Therapeutics Inc.
Outlook Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.25
13.11.25
13.11.25
-
13.11.26
13.11.26
21.74%
17.11.25
17.11.25
Could be worthwhile Investment >10% per year
Capable Management
Little innovation
